marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
NanoViricides Financial Ratios 2011-2024 | NNVC
Annual Financial Ratios NanoViricides
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.1 | -1.6 | -2.4 | -3.7 | -2.6 | -2.0 | -2.9 | -8.6 | -9.4 | -38.6 | -15.0 | -17.0 | -11.6 | -25.1 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.7 | -0.7 | -0.7 | -0.8 | -2.4 | -2.4 | -0.1 | -0.2 | -0.2 | -0.0 | -0.3 | -0.2 | -0.0 | -0.1 |
EV (Enterprise Value) |
13.8 M | 7.95 M | 5.84 M | 12.2 M | 23 M | 16.8 M | 18.5 M | 80.5 M | 90.3 M | 65.8 M | 191 M | 145 M | 59.3 M | 154 M |
EBITDA per Share |
-0.65 | -0.71 | -0.64 | -0.74 | -1.3 | -2.22 | -2.66 | -2.97 | -2.84 | -2.39 | -3.3 | -2.78 | -2.74 | -2.97 |
EV/EBITDA |
-1.5 | -3.0 | -1.8 | -2.0 | -8.7 | -10.4 | -9.0 | -21.7 | -22.1 | -9.8 | -26.0 | |||
PEG |
0.11 | 0.08 | 0.1 | 0.17 | -6.17 | -0.25 | -0.12 | -0.82 | 0.03 | -0.45 | 0.32 | 0.48 | -0.58 | 1.01 |
P/B |
1.5 | 0.9 | 0.8 | 1.1 | 1.6 | 1.6 | 1.4 | 4.4 | 4.4 | 2.7 | 7.4 | 18.9 | 5.2 | 16.0 |
P/CF |
-2.7 | -2.5 | -3.3 | -4.0 | -5.2 | -2.4 | -3.1 | -11.0 | -13.8 | -6.5 | -18.3 | -25.8 | -16.8 | -34.6 |
ROE % |
-72.35 | -57.77 | -35.12 | -29.49 | -61.80 | -79.47 | -48.48 | -50.71 | -46.53 | -6.92 | -49.31 | -110.81 | -44.82 | -63.68 |
ROA % |
-64.68 | -50.82 | -34.50 | -29.15 | -56.23 | -62.64 | -46.17 | -38.16 | -29.28 | -4.97 | -31.65 | -54.10 | -39.71 | -60.21 |
ROCE % |
-74.29 | -60.16 | -35.15 | -29.23 | -36.75 | -81.69 | -52.79 | -42.98 | -29.64 | -16.20 | -20.00 | -43.27 | -43.91 | -63.21 |
Current Ratio |
9.4 | 8.3 | 56.9 | - | 6.5 | 1.0 | 8.3 | 3.3 | 3.6 | 52.7 | 30.7 | 12.3 | 8.2 | 16.3 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios NanoViricides
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | - | -0.18 | -0.17 | - | -0.15 | -0.15 | -0.14 | -0.29 | -0.16 | -0.17 | -0.23 | -0.39 | -0.19 | -0.22 | -0.22 | -0.44 | -1.24 | -0.5 | -0.41 | -0.5 | -0.41 | -0.64 | -0.53 | -0.03 | -0.03 | -0.04 | -0.03 | -0.08 | -0.05 | -0.03 | -0.05 | -0.03 | -0.05 | -0.05 | -0.02 | -0.05 | -0.02 | -0.03 | 0.02 | -0.03 | 0.02 | -0.03 | -0.14 | -0.16 | -0.13 | -0.03 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | -0.009 | -0.01 |
EBITDA per Share |
-0.22 | - | -0.17 | -0.16 | - | -0.14 | -0.14 | -0.12 | -0.27 | -0.14 | -0.15 | -0.21 | -0.36 | -0.18 | -0.2 | -0.2 | -0.2 | -0.36 | -0.38 | -0.47 | -0.38 | -0.47 | -0.63 | -0.54 | -0.03 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
ROE % |
-80.09 | -41.51 | -50.85 | -42.65 | -25.41 | -39.77 | -37.67 | -36.15 | -38.10 | -38.89 | -38.26 | -39.40 | -38.56 | -31.80 | -32.90 | -49.46 | -66.03 | -82.59 | -91.98 | -83.14 | -74.30 | -65.46 | -59.88 | -61.33 | -56.04 | -57.49 | -56.80 | -47.31 | -51.61 | -40.75 | -43.21 | -44.91 | -34.03 | -36.05 | -26.88 | -23.26 | -16.36 | -15.68 | -9.26 | -22.31 | -103.94 | -112.46 | -168.15 | -157.44 | -92.55 | -84.70 | -45.42 | -48.15 | -44.06 | -49.02 | -46.13 | -10.01 | -13.68 | -11.21 |
ROA % |
-70.96 | -37.72 | -46.88 | -39.68 | -24.86 | -38.97 | -36.94 | -35.52 | -37.36 | -38.23 | -37.54 | -38.67 | -37.03 | -31.79 | -39.34 | -47.63 | -56.67 | -61.26 | -58.89 | -57.16 | -53.65 | -51.35 | -49.67 | -46.59 | -41.68 | -40.01 | -37.51 | -30.65 | -31.66 | -25.52 | -26.45 | -28.32 | -22.46 | -24.52 | -19.12 | -16.28 | -11.45 | -9.46 | -4.77 | -6.77 | -34.64 | -40.66 | -67.38 | -69.16 | -55.60 | -53.02 | -39.58 | -42.10 | -38.74 | -43.94 | -43.00 | -9.21 | -12.93 | -10.60 |
ROCE % |
- | - | -9.23 | -18.46 | -25.98 | -31.73 | -38.95 | -36.98 | -38.68 | -38.86 | -38.25 | -39.25 | -38.21 | -31.31 | -33.18 | -46.09 | -63.65 | -76.55 | -89.84 | -85.80 | -74.79 | -70.74 | -61.73 | -59.65 | -56.08 | -52.31 | -48.70 | -42.84 | -40.62 | -34.96 | -33.97 | -30.10 | -26.55 | -23.65 | -20.59 | -20.87 | -18.98 | -18.38 | -16.77 | -19.32 | -23.95 | -27.89 | -32.52 | -33.13 | -37.44 | -38.29 | -42.59 | -44.64 | -42.22 | -46.39 | -45.17 | -10.02 | -13.15 | -11.21 |
Current Ratio |
7.2 | - | 14.1 | 6.3 | 8.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.0 | - | - | 21.0 | 5.8 | 3.0 | 3.7 | 4.0 | 4.0 | 2.6 | 2.4 | 2.7 | 2.7 | 3.3 | 3.6 | 3.6 | 3.6 | 2.8 | 2.9 | 2.1 | 4.0 | 1.4 | 1.5 | 1.3 | 1.9 | - | 8.1 | 8.8 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency